R J G Chalmers
Affiliation: University of Manchester
- Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?Rorert Chalmers
Dermatology Centre, Hope Hospital, Salford, Manchester
Clin Med 5:230-4. 2005..The NHS needs to listen to its users, ie the patients, and to its clinical staff, and to encourage them to engage in research to help reduce those uncertainties...
- Methotrexate for psoriasis in the era of biological therapyR B Warren
Department of Dermatological Sciences, Salford Royal Hospital, University of Manchester, Manchester, UK
Clin Exp Dermatol 33:551-4. 2008..Furthermore, the potential for personalized methotrexate use by application of modern pharmacogenetics and pharmacokinetics may ensure its place as a first-line agent for the treatment of psoriasis for the foreseeable future...
- Assessing psoriasis severity and outcomes for clinical trials and routine clinical practiceRobert J G Chalmers
Department of Dermatology, Manchester Royal Infirmary, Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, 16 Oaker Avenue, West Didsbury, Manchester M20 2XH, UK Electronic address
Dermatol Clin 33:57-71. 2015..There may be benefits in terms of patient ownership of disease management from using self-assessment tools for documenting severity, for example, the Self-assessment version of the Simplified Psoriasis Index. ..
- Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysisR J G Chalmers
Dermatology Centre, University of Manchester, Hope Hospital, Salford, Manchester M6 8HD, UK
Br J Dermatol 152:444-50. 2005..More recently, monitoring by serum procollagen III aminopeptide (PIIINP) measurement (Orion Diagnostica, Espoo, Finland) has been advocated as a means of significantly reducing the need for liver biopsy...
- Care of patients with psoriasis: an audit of U.K. services in secondary careD J Eedy
Department of Dermatology, Southern Health and Social Care Trust, 68 Lurgan Road, Portadown BT9 6NY, UK
Br J Dermatol 160:557-64. 2009..The British Association of Dermatologists (BAD) commissioned an audit of the provision of care for patients with psoriasis...
- Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort studyV Madan
The Dermatology Centre, Salford Royal Hospitals NHS Foundation Trust, Salford, UK
Clin Exp Dermatol 35:27-30. 2010..Objectives. To evaluate the efficacy of a specially formulated preparation of tacrolimus 0.3% in clobetasol propionate 0.05% ointment (TCPO) in the treatment of CLE...
- A classification of psoriasis vulgaris according to phenotypeC E M Griffiths
Dermatology Centre, The University of Manchester, Hope Hospital, Salford, Manchester, UK
Br J Dermatol 156:258-62. 2007..A meeting of the International Psoriasis Council produced a consensus on clinical phenotypes of psoriasis equally relevant to clinical practitioners and psoriasis researchers...
- Fumaric acid esters for severe psoriasis: a retrospective review of 58 casesM J Harries
The Dermatology Centre, The University of Manchester, Hope Hospital, Stott Lane, Salford, Manchester, UK
Br J Dermatol 153:549-51. 2005..A recent systematic review has shown FAE to be an effective systemic treatment for severe psoriasis. However, FAE remain unlicensed in the U.K...
- Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumabC L Reddick
The Dermatology Centre, University of Manchester, Salford Royal Foundation Hospital, Manchester, United Kingdom
Dermatol Online J 16:15. 2010..To date, there is less evidence about the use of adalimumab for these conditions. We report a patient with severe superficial PG on a background of HS, which responded to adalumimab therapy after failure of infliximab therapy...
- The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trialC E M Griffiths
Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Br J Dermatol 155:393-400. 2006..There is a marked variation in the frequency of referrals between practices reflecting, in part, inadequate training of general practitioners (GPs) in the management of psoriasis...
- Inpatient management of psoriasis: a multicentre service review to establish national admission standardsA L Woods
Skin Therapy Research Unit, St John s Institute of Dermatology, St Thomas Hospital, and Imperial College, London SE1 9RT, UK
Br J Dermatol 158:266-72. 2008..There is a need for evidence-based national standards for inpatient management of psoriasis taking account of factors that predict length of stay...
- British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005C H Smith
St John s Institute of Dermatology, GKT School of Medicine, St Thomas Hospital, London SE1 7EH, UK
Br J Dermatol 153:486-97. 2005
- Contact urticaria due to p-chloro-m-cresolS L Walker
Br J Dermatol 151:936-7. 2004
- Streptococcal infection may make psoriasis worse but do antibiotics help?C M Owen
Br J Dermatol 151:244-5; author reply 245. 2004